Gastric cancer and flow cytometry

The beginning of a promising match

Research output: Contribution to journalArticle

Abstract

Gastric cancer (GC) is still a diffuse and aggressive disease in many countries where its frequency has not drastically decreased as in the USA. Furthermore, except in Japan and few other countries where the health care system has implemented effective strategies to diagnose the disease very early, GC therapy is unsatisfactory because of the advanced stage at which it is disclosed. Recent advances in the understanding of GC, resulting from identification of Helicobacter pylori as a critical factor in its development, seem not to have changed the situation. Studies on GC have often adopted flow-cytometry to investigate many parameters mostly related to prognosis. Unfortunately the results obtained with this important technique have been disappointing and diverse, which has caused a fair amount of skepticism as to its role. Starting from a critical review of the vast Literature on the topic, this paper discusses a re-evaluation of the role of flow-cytometry in the fight against GC.

Original languageEnglish
Pages (from-to)2279-2284
Number of pages6
JournalAnticancer Research
Volume17
Issue number3 C
Publication statusPublished - 1997

Fingerprint

Stomach Neoplasms
Flow Cytometry
Helicobacter pylori
Japan
Delivery of Health Care
Therapeutics

Keywords

  • Flow cytometry
  • Laboratory diagnosis
  • Prognosis
  • Stomach neoplasms

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Gastric cancer and flow cytometry : The beginning of a promising match. / Melato, Mauro.

In: Anticancer Research, Vol. 17, No. 3 C, 1997, p. 2279-2284.

Research output: Contribution to journalArticle

@article{6abf806dda0b42c0ade31241d321d657,
title = "Gastric cancer and flow cytometry: The beginning of a promising match",
abstract = "Gastric cancer (GC) is still a diffuse and aggressive disease in many countries where its frequency has not drastically decreased as in the USA. Furthermore, except in Japan and few other countries where the health care system has implemented effective strategies to diagnose the disease very early, GC therapy is unsatisfactory because of the advanced stage at which it is disclosed. Recent advances in the understanding of GC, resulting from identification of Helicobacter pylori as a critical factor in its development, seem not to have changed the situation. Studies on GC have often adopted flow-cytometry to investigate many parameters mostly related to prognosis. Unfortunately the results obtained with this important technique have been disappointing and diverse, which has caused a fair amount of skepticism as to its role. Starting from a critical review of the vast Literature on the topic, this paper discusses a re-evaluation of the role of flow-cytometry in the fight against GC.",
keywords = "Flow cytometry, Laboratory diagnosis, Prognosis, Stomach neoplasms",
author = "Mauro Melato",
year = "1997",
language = "English",
volume = "17",
pages = "2279--2284",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "3 C",

}

TY - JOUR

T1 - Gastric cancer and flow cytometry

T2 - The beginning of a promising match

AU - Melato, Mauro

PY - 1997

Y1 - 1997

N2 - Gastric cancer (GC) is still a diffuse and aggressive disease in many countries where its frequency has not drastically decreased as in the USA. Furthermore, except in Japan and few other countries where the health care system has implemented effective strategies to diagnose the disease very early, GC therapy is unsatisfactory because of the advanced stage at which it is disclosed. Recent advances in the understanding of GC, resulting from identification of Helicobacter pylori as a critical factor in its development, seem not to have changed the situation. Studies on GC have often adopted flow-cytometry to investigate many parameters mostly related to prognosis. Unfortunately the results obtained with this important technique have been disappointing and diverse, which has caused a fair amount of skepticism as to its role. Starting from a critical review of the vast Literature on the topic, this paper discusses a re-evaluation of the role of flow-cytometry in the fight against GC.

AB - Gastric cancer (GC) is still a diffuse and aggressive disease in many countries where its frequency has not drastically decreased as in the USA. Furthermore, except in Japan and few other countries where the health care system has implemented effective strategies to diagnose the disease very early, GC therapy is unsatisfactory because of the advanced stage at which it is disclosed. Recent advances in the understanding of GC, resulting from identification of Helicobacter pylori as a critical factor in its development, seem not to have changed the situation. Studies on GC have often adopted flow-cytometry to investigate many parameters mostly related to prognosis. Unfortunately the results obtained with this important technique have been disappointing and diverse, which has caused a fair amount of skepticism as to its role. Starting from a critical review of the vast Literature on the topic, this paper discusses a re-evaluation of the role of flow-cytometry in the fight against GC.

KW - Flow cytometry

KW - Laboratory diagnosis

KW - Prognosis

KW - Stomach neoplasms

UR - http://www.scopus.com/inward/record.url?scp=0030860492&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030860492&partnerID=8YFLogxK

M3 - Article

VL - 17

SP - 2279

EP - 2284

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 3 C

ER -